Mode
Text Size
Log in / Sign up
N/A N=64 Randomized Single-blind Supportive Care

Move For Your Health for Older Cancer Survivors

Cancer Survivors

Enrolled (actual)
64
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcome: Primary: Time to Accrual Goal — 9; 9 months

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Fitbit Intervention (Behavioral)
Age
Older Adult · 65+ yrs
Sex
All
Sponsor
University of New Mexico
Primary completion
Mar 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Time to Accrual Goal
9; 9
PRIMARY
Study Participant Retention Rate
27; 26
PRIMARY
Study Participant Adherence Rate
29; 26
PRIMARY
Number of Adverse Events Attributable to the Study
0; 1
PRIMARY
Change in Self-reported Physical Function
1.31; 0.22
PRIMARY
Number of Adverse Events Attributable to the Study
0; 1
SECONDARY
Change in the Number of Chair Stands During the 30-second Chair Stand Test
0.0; 0.0
SECONDARY
Change in Balance Score During the 4-stage Balance Test.
0.1; 0.0
SECONDARY
Change in Number of Steps Per Day
296; 542
SECONDARY
Change in Objective Measures of Light-intensity Physical Activity
6.3; 9.8
SECONDARY
Change in Objective Measures of Moderate-intensity Physical Activity
3.3; 5.2
SECONDARY
Change in Objective Measures of Sedentary Activity
-10.1; -4.4
SECONDARY
Change in Self-reported Fatigue
-0.31; -2.97
SECONDARY
Change in Self-reported Pain
0.41; -0.91
SECONDARY
Change in Self-reported Sleep Disturbance
-0.78; -2.38
SECONDARY
Change in Self-reported Sleep Impairment
0.22; -1.09
SECONDARY
Change in Self-reported Social Participation
-1.28; 1.00
SECONDARY
Change in Self-reported Anxiety
-0.75; -0.47
SECONDARY
Change in Self-reported Depression
-1.94; 0.19

Summary

The Move for Your Health (MY Health) Pilot Study is a 12-week study for older cancer survivors to promote light physical activity. The home-based study (no travel required) will test whether a Fitbit activity tracker and health coaching can help cancer survivors be more active throughout the day.

Eligibility Criteria

Inclusion Criteria

  • Diagnosed in New Mexico (NM) with a loco-regionally staged cancer, completed primary treatment (surgery, radiation, chemotherapy), and not currently being treated for a recurrence. Patients with metastatic cancer are eligible with physician approval.
  • Mild-to-moderate physical functional impairment (raw score between 20 and 34 on the 8-item PROMIS Physical Function survey)
  • Able to speak, read, & understand English or Spanish
  • Participating in less than 120 minutes per week of moderate-intensity physical activity
  • Living independently and capable of walking 3 blocks (approximately 1300 steps or 0.25 mile) without an assistive device (e.g., cane, walker) and without stopping to rest
  • Own a smartphone or tablet *OR* be willing to use a study-provided smartphone capable of running the Fitbit app. Also, access to the internet or a Wi-Fi hotspot at least once per week is required. Smartphones and data plans will be provided to those individuals who are eligible but do not currently own a device capable of running the Fitbit app.
  • Availability of a family member or friend to be present (for safety) during the remote assessment of physical performance tests
  • Willingness to be randomized to either study arm and to wear activity trackers

Exclusion Criteria

  • Adults not able to consent
  • Severe impairments (in seeing or hearing) or pre-existing medical limitations for engaging in daily light physical activity (e.g., severe orthopedic conditions, pending hip/knee replacement, dementia, oxygen dependent, chronic vertigo)
  • Paid employment or volunteer position for greater than 20 hours per week (to avoid potential confounding by occupation activity/inactivity)
  • Currently participating in a program (personal program, e.g., wearing an activity monitor, or structured program, e.g., another study) to decrease sedentary time or increase physical activity
  • Planning to move out of New Mexico within the next year
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05582889). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search